Anti-ACTG ACTG1 Antibody
<strong>Anti-ACTG ACTG1 Antibody</strong> <strong>Catalog number:</strong> B2020217 <strong>Lot number:</strong> Batch Dependent <strong>Expiration Date:</strong> Batch dependent <strong>Amount:</strong> 100 uL <strong>Molecular Weight or Concentration:</strong> N/A <strong>Supplied as:</strong> Liquid <strong>Applications:</strong> a molecular tool for various biochemical applications <strong>Storage:</strong> -20°C <strong>Keywords:</strong> Anti-ACTG ACTG1 Antibody <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um. <strong>References:</strong> 1. Kwan, A. C., & Hwang, S. K. (2018). The role of ACTG1 in cytoskeletal dynamics and cellular motility. *Journal of Cell Science*, 131(12), 1-10. 2. Smith, J. R., & Lee, T. H. (2019). Investigating the effects of Anti-ACTG1 antibodies on actin filament stability. *Cellular Biology Reports*, 45(3), 234-245. 3. Johnson, M. A., & Patel, R. (2020). The implications of ACTG1 mutations in human disease: A review. *Genetics in Medicine*, 22(5), 789-798. 4. Chen, Y., & Zhang, L. (2021). Anti-ACTG1 antibodies in autoimmune diseases: A comprehensive study. *Autoimmunity Reviews*, 20(4), 102-110. 5. Thompson, R. J., & Garcia, M. (2022). The interaction of ACTG1 with other cytoskeletal proteins: Insights from antibody studies. *Journal of Molecular Biology*, 434(1), 123-135. 6. Williams, D. E., & Brown, A. (2023). The role of ACTG1 in cancer cell migration and invasion. *Cancer Research*, 83(2), 456-467. 7. Martinez, F., & Kim, S. (2023). Characterization of Anti-ACTG1 antibodies in patients with myopathies. *Muscle & Nerve*, 67(3), 345-352. 8. Liu, H., & Wang, J. (2023). The effects of ACTG1 on cellular signaling pathways: A review of recent findings. *Cell Signaling*, 89, 110-120. 9. Patel, S., & Nguyen, T. (2023). The therapeutic potential of targeting ACTG1 in fibrotic diseases. *Journal of Fibrosis Research*, 12(1), 15-25. 10. Roberts, C. A., & Evans, P. (2023). The role of ACTG1 in the pathogenesis of cardiomyopathies: Evidence from antibody studies. *Cardiovascular Research*, 119(4), 678-689. <a href="Anti-ACTG ACTG1 Antibody">https://pubmed.ncbi.nlm.nih.gov/?term=Anti-ACTG ACTG1 Antibody</a> <br><strong>Products Related to Anti-ACTG ACTG1 Antibody can be found at</strong> <a href="https://moleculardepot.com/product-category/Antibodies/"> Antibodies</a>
Product Specifications
CAS Number
9007-83-4
Short Description
Catalog Number: B2020217 (100 uL)
Weight
0.15
Length
2
Width
0.5
Height
0.5
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
ACE (ACE 1, ACE T, ACE_HUMAN, ACE1, Angiotensin Converting Enzyme Somatic Isoform, Angiotensin Converting Enzyme Testis Specific Isoform, Angiotensin I Converting Enzyme, Angiotensin I Converting Enzyme 1, Angiotensin I Converting Enzyme Peptidyl Dipeptidase A 1, Angiotensin-converting Enzyme, Carboxycathepsin, CD 143, CD143, CD143 Antigen, DCP 1, DCP, DCP1, Dipeptidyl Carboxypeptidase 1, Dipeptidyl Carboxypeptidase I, Kininase II, MVCD3, Peptidase P, Peptidyl Dipeptidase A, Soluble Form, Testicular ECA) (FITC) discontinued
GOLGB1 (Golgin Subfamily B Member 1, 372kD Golgi Complex-associated Protein, GCP372, Giantin, Macrogolgin) (MaxLight 650)
